Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIROX: FOLFOX 4 vs FOLFOX 7 - FOLFIRI in Colorectal Cancer
NCT00268398Phase 3Completed
- Sponsor
- GERCOR
- Start
- Jul 2002
- Primary completion
- Dec 2011
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, irinotecan, fluorouracil, folinic acid in colorectal cancer (CRC), sponsored by GERCOR. Started Jul 2002; status: completed.
02
Drugs
oxaliplatinirinotecanfluorouracilfolinic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00268398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268398.